Defective thrombus formation in mice lacking coagulation factor XII

612Citations
Citations of this article
264Readers
Mendeley users who have this article in their library.

Abstract

Blood coagulation is thought to be initiated by plasma protease factor VIIa in complex with the membrane protein tissue factor. In contrast, coagulation factor XII (FXII)-mediated fibrin formation is not believed to play an important role for coagulation in vivo. We used FXII-deficient mice to study the contributions of FXII to thrombus formation in vivo. Intravital fluorescence microscopy and blood flow measurements in three distinct arterial beds revealed a severe defect in the formation and stabilization of platelet-rich occlusive thrombi. Although FXII-deficient mice do not experience spontaneous or excessive injury-related bleeding, they are protected against collagen- and epinephrine-induced thromboembolism. Infusion of human FXII into FXII-null mice restored injury-induced thrombus formation. These unexpected findings change the long-standing concept that the FXII-induced intrinsic coagulation pathway is not important for clotting in vivo. The results establish FXII as essential for thrombus formation, and identify FXII as a novel target for antithrombotic therapy. JEM © The Rockefeller University Press.

Cite

CITATION STYLE

APA

Renné, T., Pozgajová, M., Grüner, S., Schuh, K., Pauer, H. U., Burfeind, P., … Nieswandt, B. (2005). Defective thrombus formation in mice lacking coagulation factor XII. Journal of Experimental Medicine, 202(2), 271–281. https://doi.org/10.1084/jem.20050664

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free